All tenders
75A50123C00034
RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND
Office of Assistant Secretary for Preparedness and Response · United States
This tender closed on Saturday, May 31, 2025. Browse open opportunities
Time Left to Bid
Closed
ClosedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50123C00034
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND
- Source
- USASpending (Federal)
- Source ID
- usa-75A50123C00034
Details
- Location
- United States
Description
RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND Awarded to: NUVOX PHARMA, L.L.C. Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2023/07/28 12:00:00 AM UTC
- Closing date
- 2025/05/31 12:00:00 AM UTC
Estimated value
$356K USD
Classification
Normalized category
Healthcare & Medical